SEC Info - Anixa Biosciences Inc - ‘10-K/A’ for 10/31/19

SEC Info℠

Home

Help

Please Sign In

Anixa Biosciences Inc – ‘10-K/A’ for 10/31/19 – ‘EX-32.2’

On: Friday, 1/10/20, at 5:16pm ET · For: 10/31/19 · Accession #: 1513162-20-12 · File #: 1-37492

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/10/20  Anixa Biosciences Inc             10-K/A     10/31/19    6:1.6M                                   Zacks Inv Resear… Inc/FA

Amendment to Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K/A      Amendment to Annual Report -- form10k_a             HTML    773K 
 2: EX-23.1     Consent of Experts or Counsel -- exhibit23_1        HTML      6K 
 3: EX-31.1     Certification -- §302 - SOA'02 -- exhibit31_1       HTML     17K 
 4: EX-31.2     Certification -- §302 - SOA'02 -- exhibit31_2       HTML     17K 
 5: EX-32.1     Certification -- §906 - SOA'02 -- exhibit32_1       HTML      9K 
 6: EX-32.2     Certification -- §906 - SOA'02 -- exhibit32_2       HTML     10K

‘EX-32.2’ — Certification — §906 – SOA’02 — exhibit32_2

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Michael J. Catelani, Chief Operating Officer and Chief Financial Officer of Anixa Biosciences, Inc. (the “Company”), hereby certifies that:

The Company's Form 10-K Annual Report for the fiscal year ended October 31, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: January 10, 2020

/s/ Michael J. Catelani

Michael J. Catelani

Chief Operating Officer and

Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K/A’ Filing	Date	Other Filings

Filed on:	1/10/20
For Period end:	10/31/19	10-K, 4
		List all Filings

↑Top

Filing Submission 0001513162-20-000012 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)